Cargando…

Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling

OBJECTIVE: Exploitation of protective metabolic pathways within injured myocardium still remains an unclarified therapeutic target in heart disease. Moreover, while the roles of altered fatty acid and glucose metabolism in the failing heart have been explored, the influence of highly dynamic and nut...

Descripción completa

Detalles Bibliográficos
Autores principales: Schugar, Rebecca C., Moll, Ashley R., André d’Avignon, D., Weinheimer, Carla J., Kovacs, Attila, Crawford, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209361/
https://www.ncbi.nlm.nih.gov/pubmed/25353003
http://dx.doi.org/10.1016/j.molmet.2014.07.010
_version_ 1782341249709113344
author Schugar, Rebecca C.
Moll, Ashley R.
André d’Avignon, D.
Weinheimer, Carla J.
Kovacs, Attila
Crawford, Peter A.
author_facet Schugar, Rebecca C.
Moll, Ashley R.
André d’Avignon, D.
Weinheimer, Carla J.
Kovacs, Attila
Crawford, Peter A.
author_sort Schugar, Rebecca C.
collection PubMed
description OBJECTIVE: Exploitation of protective metabolic pathways within injured myocardium still remains an unclarified therapeutic target in heart disease. Moreover, while the roles of altered fatty acid and glucose metabolism in the failing heart have been explored, the influence of highly dynamic and nutritionally modifiable ketone body metabolism in the regulation of myocardial substrate utilization, mitochondrial bioenergetics, reactive oxygen species (ROS) generation, and hemodynamic response to injury remains undefined. METHODS: Here we use mice that lack the enzyme required for terminal oxidation of ketone bodies, succinyl-CoA:3-oxoacid CoA transferase (SCOT) to determine the role of ketone body oxidation in the myocardial injury response. Tracer delivery in ex vivo perfused hearts coupled to NMR spectroscopy, in vivo high-resolution echocardiographic quantification of cardiac hemodynamics in nutritionally and surgically modified mice, and cellular and molecular measurements of energetic and oxidative stress responses are performed. RESULTS: While germline SCOT-knockout (KO) mice die in the early postnatal period, adult mice with cardiomyocyte-specific loss of SCOT (SCOT-Heart-KO) remarkably exhibit no overt metabolic abnormalities, and no differences in left ventricular mass or impairments of systolic function during periods of ketosis, including fasting and adherence to a ketogenic diet. Myocardial fatty acid oxidation is increased when ketones are delivered but cannot be oxidized. To determine the role of ketone body oxidation in the remodeling ventricle, we induced pressure overload injury by performing transverse aortic constriction (TAC) surgery in SCOT-Heart-KO and αMHC-Cre control mice. While TAC increased left ventricular mass equally in both groups, at four weeks post-TAC, myocardial ROS abundance was increased in myocardium of SCOT-Heart-KO mice, and mitochondria and myofilaments were ultrastructurally disordered. Eight weeks post-TAC, left ventricular volume was markedly increased and ejection fraction was decreased in SCOT-Heart-KO mice, while these parameters remained normal in hearts of control animals. CONCLUSIONS: These studies demonstrate the ability of myocardial ketone metabolism to coordinate the myocardial response to pressure overload, and suggest that the oxidation of ketone bodies may be an important contributor to free radical homeostasis and hemodynamic preservation in the injured heart.
format Online
Article
Text
id pubmed-4209361
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-42093612014-10-28 Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling Schugar, Rebecca C. Moll, Ashley R. André d’Avignon, D. Weinheimer, Carla J. Kovacs, Attila Crawford, Peter A. Mol Metab Original Article OBJECTIVE: Exploitation of protective metabolic pathways within injured myocardium still remains an unclarified therapeutic target in heart disease. Moreover, while the roles of altered fatty acid and glucose metabolism in the failing heart have been explored, the influence of highly dynamic and nutritionally modifiable ketone body metabolism in the regulation of myocardial substrate utilization, mitochondrial bioenergetics, reactive oxygen species (ROS) generation, and hemodynamic response to injury remains undefined. METHODS: Here we use mice that lack the enzyme required for terminal oxidation of ketone bodies, succinyl-CoA:3-oxoacid CoA transferase (SCOT) to determine the role of ketone body oxidation in the myocardial injury response. Tracer delivery in ex vivo perfused hearts coupled to NMR spectroscopy, in vivo high-resolution echocardiographic quantification of cardiac hemodynamics in nutritionally and surgically modified mice, and cellular and molecular measurements of energetic and oxidative stress responses are performed. RESULTS: While germline SCOT-knockout (KO) mice die in the early postnatal period, adult mice with cardiomyocyte-specific loss of SCOT (SCOT-Heart-KO) remarkably exhibit no overt metabolic abnormalities, and no differences in left ventricular mass or impairments of systolic function during periods of ketosis, including fasting and adherence to a ketogenic diet. Myocardial fatty acid oxidation is increased when ketones are delivered but cannot be oxidized. To determine the role of ketone body oxidation in the remodeling ventricle, we induced pressure overload injury by performing transverse aortic constriction (TAC) surgery in SCOT-Heart-KO and αMHC-Cre control mice. While TAC increased left ventricular mass equally in both groups, at four weeks post-TAC, myocardial ROS abundance was increased in myocardium of SCOT-Heart-KO mice, and mitochondria and myofilaments were ultrastructurally disordered. Eight weeks post-TAC, left ventricular volume was markedly increased and ejection fraction was decreased in SCOT-Heart-KO mice, while these parameters remained normal in hearts of control animals. CONCLUSIONS: These studies demonstrate the ability of myocardial ketone metabolism to coordinate the myocardial response to pressure overload, and suggest that the oxidation of ketone bodies may be an important contributor to free radical homeostasis and hemodynamic preservation in the injured heart. Elsevier 2014-08-13 /pmc/articles/PMC4209361/ /pubmed/25353003 http://dx.doi.org/10.1016/j.molmet.2014.07.010 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Original Article
Schugar, Rebecca C.
Moll, Ashley R.
André d’Avignon, D.
Weinheimer, Carla J.
Kovacs, Attila
Crawford, Peter A.
Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
title Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
title_full Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
title_fullStr Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
title_full_unstemmed Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
title_short Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
title_sort cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209361/
https://www.ncbi.nlm.nih.gov/pubmed/25353003
http://dx.doi.org/10.1016/j.molmet.2014.07.010
work_keys_str_mv AT schugarrebeccac cardiomyocytespecificdeficiencyofketonebodymetabolismpromotesacceleratedpathologicalremodeling
AT mollashleyr cardiomyocytespecificdeficiencyofketonebodymetabolismpromotesacceleratedpathologicalremodeling
AT andredavignond cardiomyocytespecificdeficiencyofketonebodymetabolismpromotesacceleratedpathologicalremodeling
AT weinheimercarlaj cardiomyocytespecificdeficiencyofketonebodymetabolismpromotesacceleratedpathologicalremodeling
AT kovacsattila cardiomyocytespecificdeficiencyofketonebodymetabolismpromotesacceleratedpathologicalremodeling
AT crawfordpetera cardiomyocytespecificdeficiencyofketonebodymetabolismpromotesacceleratedpathologicalremodeling